Characteristics Frequency Percent
Drinking
Yes 3 3.2
No 92 96.8
Smoking
Yes 1 1.1
No 94 96.8
TB contact
Yes 9 9.5
No 86 90.5
With whom
Family 5 5.3
Friends 3 3.2
Prison 6 6.3
Previous TB history 44 46.3
Treated
Completed 43 45.3
Defaulter 1 1.1
HIV Stage
I 85 89.5
II 3 3.2
III 6 6.3
IV 1 1.1
ART    
Yes 93 96.8
No 3 3.2
Current Regimen
1c AZT (Zidovudine), 3TC(Lamuvidine), NVP (Nevrapine) 13 13.9
1d AZT (Zidovudine), 3TC(Lamuvidine), EFV(Efaverine) 15 16.1
1e TDF (Tenofovir), 3TC (Lamuvidine), EFV (Efaverine) 42 45.2
1f TDF (Tenofovir), 3TC (Lamuvidine), NVP (Nevrapine) 1 1.1
CD4    
≤350 32 33.7
>350 63 66.3
Table 2: Distributions of lifestyle and clinical history of 95 study participants at SPHMMC, Addis Ababa Ethiopia 2014.